Medical management of chronic pelvic pain.
Chronic pelvic pain is a symptom of poorly understood aetiology. Pelvic congestion and psychological factors have been identified as important aetiological factors but surprisingly few studies of therapies directed at these aetiologies have been performed. A limited number of trials suggest that the progestagen medroxyprogesterone acetate may be useful in relieving symptoms, but benefit may be restricted to duration of treatment only. Further research is required into both the basis of chronic pelvic pain and its medical management.
Prentice
A
A
Department of Obstetrics and Gynaecology, University of Cambridge, Rosie Hospital, UK.
D000928:Antidepressive Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004087:Dihydroergotamine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D017699:Pelvic Pain / Q000188:drug therapy* / Q000209:etiology; D010388:Pelvis / Q000098:blood supply; D045167:Progesterone Congeners / Q000627:therapeutic use; D014648:Varicose Veins / Q000150:complications; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000928:Antidepressive Agents; D045167:Progesterone Congeners; D014662:Vasoconstrictor Agents; D004087:Dihydroergotamine; D017258:Medroxyprogesterone Acetate